Impact of the Daily Use of Emollient on Corticosteroids Consumption in Patients With Atopic Dermatitis
Launched by COSMETIQUE ACTIVE INTERNATIONAL · Nov 30, 2022
Trial Information
Current as of January 17, 2025
Completed
Keywords
ClinConnect Summary
The study is conducted in compliance, as closely as possible, with the current version of the world medical association declaration of Helsinki, local regulations based on International Council on Harmonisation (ICH) guidelines for Good Clinical Practice.
The primary objective of this study is to compare the tested emollient and the usual emollient through the weight of used dermocorticosteroid. The weight of used dermocorticosteroid is compared at the end of the study by a Student t-test (or a non parametric Wilcoxon test depending on the data distribution).
The following hypotheses are ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • diagnosis of atopic dermatitis must meet Hanifin's criteria (at least 3 basic features and at least 3 minor features)
- • mild atopic dermatitis present for at least 6 months before inclusion (SCORAD at inclusion between 20 and 30)
- • able to apply the emollient (each morning and evening) during a three-month period
- Exclusion Criteria:
- • presenting with another dermatological condition that could interfere with clinical evaluation
- • having received any systemic treatment, including PUVAtherapy for atopic dermatitis in the month prior to Day 0
- • who intend to expose themselves to the sun during the trial
Trial Officials
Caroline Le Floc'h
Study Director
Cosmetique Active International
About Cosmetique Active International
Cosmetique Active International is a leading global sponsor of clinical trials focused on the development and evaluation of innovative cosmetic and dermatological products. Committed to advancing skin health and beauty, the organization leverages cutting-edge research methodologies and robust clinical protocols to ensure the safety and efficacy of its formulations. With a multidisciplinary team of experts in dermatology, pharmacology, and regulatory affairs, Cosmetique Active International collaborates with diverse stakeholders to drive scientific advancements and deliver high-quality cosmetic solutions that meet the evolving needs of consumers and healthcare professionals alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Svidník, , Slovakia
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials